long-arrow-pointing-to-left linkedin twitter facebook mail

Are You Set Up for Success?

A single mistake during the Developmental and Reproductive Toxicology phase can waste considerable investment dollars, delay launch, or worse -- lead to a drug or vaccine that goes to market with DART effects missed in the study. These questions can help mitigate the risk of missteps in your DART study.


what’s inside

Are you using tox generalists to perform DART Analysis?

DART studies require researchers with the specialized experience to evaluate subtle changes and make subjective interpretations.

Does your team have enough control data to define "normal?"

DART professionals use relevant historical control data to identify which abnormalities truly fall outside the normal range for each species.

Are your dart researchers asking the right questions?

Seasoned DART investigators use their knowledge of FDA requirements, drug development plan, and preclinical data for effective study design.

Can your team properly defend and document research analysis?

Study results properly documented and interpreted by a DART researcher may have a higher likelihood of FDA acceptance.


apply what you learn

At Battelle, we don’t just conduct studies — we solve problems. Our experts can help you cut through the complexity of DART study design and develop a program that meets your needs both technically and strategically. 

Download your copy of Is Your DART Study Set Up to Fail? Developmental and Reproductive Toxicology Study Design and Execution by providing a little information on the right.

get the white paper

This field is required Would you like to receive updates from Battelle?

Please refer to our PRIVACY POLICY for more information.